Lungpacer Medical Announces Investigational Device Exemption (IDE) for STARI, Phase 2 Feasibility Clinical Trial
The investigational AeroNova® System delivers continual diaphragm neurostimulation in conjunction with mechanical ventilation ...
MassDevice2d
Lungpacer wins FDA IDE for AeroNova system
Lungpacer Medical announced that it received FDA investigational device exemption (IDE) approval to begin a trial for its ...
Medscape8d
Bilateral diaphragmatic paralysis and related respiratory complications in a patient with West Nile virus infection.
The case report is presented of a patient with West Nile virus infection and ventilator dependent respiratory failure in whom bilateral diaphragmatic paralysis developed. If the prevalence of West ...
Morningstar2d
Lungpacer Medical Announces Investigational Device Exemption (IDE) for STARI, Phase 2 Feasibility Clinical Trial
Through DNAV, the AeroNova System will provide bilateral diaphragm activity that allows reduced positive pressure from the ventilator while maintaining patient respiration. “This is an important ...